TCG Crossover Management as of March 31, 2023
Portfolio Holdings for TCG Crossover Management
TCG Crossover Management holds 22 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iveric Bio Comm | 24.4 | $125M | 5.1M | 24.33 | |
| Cogent Biosciences Comm (COGT) | 7.6 | $39M | 3.6M | 10.79 | |
| Geron Corp Comm (GERN) | 7.5 | $39M | 18M | 2.17 | |
| Madrigal Pharmaceuticals Comm (MDGL) | 7.1 | $36M | 150k | 242.26 | |
| Tyra Biosciences Comm (TYRA) | 6.2 | $32M | 2.0M | 16.07 | |
| Ventyx Biosciences Comm (VTYX) | 5.3 | $27M | 816k | 33.50 | |
| Kalvista Pharmaceuticals Comm (KALV) | 5.2 | $27M | 3.4M | 7.86 | |
| Cymabay Therapeutics Comm | 5.2 | $27M | 3.0M | 8.72 | |
| Vectivbio Holding Comm | 5.2 | $27M | 3.1M | 8.51 | |
| Aerovate Therapeutics Comm (AVTE) | 4.3 | $22M | 1.1M | 20.17 | |
| Dyne Therapeutics Comm (DYN) | 3.7 | $19M | 1.7M | 11.52 | |
| Kura Oncology Comm (KURA) | 3.4 | $17M | 1.4M | 12.23 | |
| Viridian Therapeutics Comm (VRDN) | 3.3 | $17M | 664k | 25.44 | |
| Silence Therapeutics Ads (SLN) | 2.5 | $13M | 2.1M | 6.20 | |
| Immunovant Comm (IMVT) | 2.0 | $10M | 655k | 15.51 | |
| Entrada Therapeutics Comm (TRDA) | 1.7 | $8.5M | 585k | 14.50 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.6 | $8.3M | 350k | 23.79 | |
| Merus Bv Comm (MRUS) | 1.1 | $5.5M | 300k | 18.40 | |
| Aclaris Therapeutics Comm (ACRS) | 0.8 | $4.3M | 530k | 8.09 | |
| Cabaletta Bio Comm (CABA) | 0.8 | $4.0M | 487k | 8.27 | |
| C4 Therapeutics Comm (CCCC) | 0.8 | $3.9M | 1.3M | 3.14 | |
| Alpine Immune Sciences Comm | 0.4 | $2.0M | 253k | 7.72 |
